Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -125.30% is 22% above its 5-year average of -159.98%, near the high end of its 5-year range (-441.94%–-59.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 40.12% below its 12-month average of -89.42%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -125.30%.
RETURN ON EQUITY (ROE)
-125.30%
RETURN ON EQUITY (ROE) AVG TTM
-89.42%
RETURN ON EQUITY (ROE) AVG 3Y
-89.42%
RETURN ON EQUITY (ROE) AVG 5Y
-159.98%
RETURN ON EQUITY (ROE) AVG 10Y
-23.45%
RETURN ON EQUITY (ROE) AVG 15Y
-73.02%
RETURN ON EQUITY (ROE) AVG 20Y
-95.80%
CURRENT VS TTM AVG
-40.12%
CURRENT VS 3Y AVG
-40.12%
CURRENT VS 5Y AVG
+21.68%
CURRENT VS 10Y AVG
-434.25%
CURRENT VS 15Y AVG
-71.58%
CURRENT VS 20Y AVG
-30.79%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-198.25%
vs the sector median at left
Palatin Technologies, Inc.
Market Cap
$17.14M
Return on Equity (ROE)
-125.30%
TTM Avg
-89.42%
3Y Avg
-89.42%
5Y Avg
-159.98%
Market Cap
$17.11M
Return on Equity (ROE)
-54.45%
TTM Avg
-33.23%
3Y Avg
-44.23%
5Y Avg
-52.50%
Market Cap
$16.75M
Return on Equity (ROE)
-101.76%
TTM Avg
-188.04%
3Y Avg
-167.76%
5Y Avg
-134.95%
Market Cap
$16.67M
Return on Equity (ROE)
-71.57%
TTM Avg
-65.12%
3Y Avg
-85.39%
5Y Avg
-90.29%
Market Cap
$17.68M
Return on Equity (ROE)
-34.50%
TTM Avg
-796.82%
3Y Avg
-138.82%
5Y Avg
-407.45%
Market Cap
$16.53M
Return on Equity (ROE)
-170.55%
TTM Avg
-79.16%
3Y Avg
-71.01%
5Y Avg
-42.13%
Market Cap
$16.50M
Return on Equity (ROE)
N/A
TTM Avg
-416.37%
3Y Avg
-259.03%
5Y Avg
-190.00%
Market Cap
$17.84M
Return on Equity (ROE)
-117.98%
TTM Avg
-84.94%
3Y Avg
-64.05%
5Y Avg
-76.29%
Market Cap
$17.99M
Return on Equity (ROE)
N/A
TTM Avg
-3014.83%
3Y Avg
-1589.49%
5Y Avg
-1032.64%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palatin Technologies, Inc. (PTN) | $17.14M | -125.30% | -89.42% | -89.42% | -159.98% |
| Lipocine Inc. (LPCN)vs › | $17.11M | -54.45% | -33.23% | -44.23% | -52.50% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | -101.76% | -188.04% | -167.76% | -134.95% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.67M | -71.57% | -65.12% | -85.39% | -90.29% |
| PAVmed Inc. (PAVM)vs › | $17.68M | -34.50% | -796.82% | -138.82% | -407.45% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.53M | -170.55% | -79.16% | -71.01% | -42.13% |
| Dyadic International, Inc. (DYAI)vs › | $16.50M | N/A | -416.37% | -259.03% | -190.00% |
| Cosmos Health Inc. (COSM)vs › | $17.84M | -117.98% | -84.94% | -64.05% | -76.29% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | N/A | -3014.83% | -1589.49% | -1032.64% |
| BioCardia, Inc. (BCDA)vs › | $15.79M | -271.81% | -934.34% | -347.56% | -265.02% |
ROE
-125.3%
ROA
-98.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -125.30% |
| 2026-03-31 | -59.00% |
| 2025-12-31 | -83.97% |
| 2023-03-31 | -281.31% |
| 2022-12-31 | -158.76% |
| 2022-09-30 | -441.94% |
| 2022-06-30 | -222.51% |
| 2022-03-31 | -133.04% |
| 2021-12-31 | -100.76% |
| 2021-09-30 | -85.57% |
| 2021-06-30 | -67.66% |
| 2021-03-31 | -42.88% |
| 2020-12-31 | -39.23% |
| 2019-12-31 | 40.23% |
| 2019-09-30 | 38.44% |
| 2019-06-30 | 35.58% |
| 2019-03-31 | -28.90% |
| 2018-12-31 | 1.63% |
| 2018-09-30 | 33.44% |
| 2018-06-30 | 91.61% |
| 2018-03-31 | 256.30% |
| 2017-12-31 | 242.93% |
| 2017-09-30 | 172.78% |
| 2015-12-31 | -627.34% |
| 2015-09-30 | -152.56% |
| 2015-06-30 | -144.75% |
| 2015-03-31 | -41.27% |
| 2014-12-31 | -6.92% |
| 2014-09-30 | -80.06% |
| 2014-06-30 | -142.29% |
| 2014-03-31 | -102.41% |
| 2013-12-31 | -110.26% |
| 2013-09-30 | -79.81% |
| 2013-06-30 | -90.79% |
| 2013-03-31 | -77.53% |
| 2012-12-31 | -74.38% |
| 2012-09-30 | -73.80% |
| 2012-06-30 | -942.33% |
| 2012-03-31 | -221.61% |
| 2011-12-31 | -103.39% |
| 2011-09-30 | -76.89% |
| 2011-06-30 | -70.45% |
| 2011-03-31 | -85.04% |
| 2010-12-31 | -296.65% |
| 2010-09-30 | -125.02% |
| 2010-06-30 | -19.24% |
| 2010-03-31 | 19.40% |
| 2009-12-31 | 39.22% |
| 2009-09-30 | -8.68% |
| 2009-06-30 | -144.93% |
| 2009-03-31 | -311.61% |
| 2008-12-31 | -557.69% |
| 2008-09-30 | -661.59% |
| 2008-06-30 | -219.54% |
| 2008-03-31 | -135.82% |
| 2007-12-31 | -107.34% |
| 2007-09-30 | -103.71% |
| 2007-06-30 | -149.75% |
| 2007-03-31 | -122.45% |
| 2006-12-31 | -635.78% |
| 2006-09-30 | -310.65% |
| 2006-06-30 | -158.25% |
| 2005-12-31 | -331.77% |
| 2005-09-30 | -128.26% |
| 2005-06-30 | -155.64% |
| 2005-03-31 | -117.43% |
| 2004-12-31 | -114.71% |
| 2004-09-30 | -114.07% |
| 2004-06-30 | -135.75% |
| 2004-03-31 | -98.65% |
| 2003-12-31 | -183.93% |
| 2003-09-30 | -173.78% |
| 2003-06-30 | -110.23% |
